infectious diseases

News

Gates Foundation, Wellcome put $550m behind new TB jab

A potentially game-changing new vaccine for tuberculosis is set for a major clinical trials programme, thanks to $550 million in funding from philanthropic organisations t

News

CDC panel backs use of GSK, Pfizer’s RSV shots this year

Adults aged 60 and over in the US will be eligible for vaccinations with respiratory syncytial virus (RSV) vaccines from GSK or Pfizer later this year, if the Centers for

Digital

What would you do if you had 6 months' lead time?

In March 2015, Brazil reported a large outbreak of a mysterious illness causing fever and rash.

R&D

CSL reflects on its future, past as new R&D lab opens

Last month, global pharmaceutical maker CSL cut the ribbon on a brand-new research facility in Waltham, Massachusetts, wher

News

BiomX reports “impressive” data in first bacteriophage trial

BCX004 cocktail led to a five-fold reduction in bacterial burden in cystic fibrosis patients.

News

Dengue, zika and chikungunya fever mosquito (aedes aegypti) on human skin

Valneva eyes first place in chikungunya vaccine race

Valneva has moved a step closer to its goal of becoming the first company to file for approval of a vaccine against chikungunya virus in the US after reporting new clinical data today.

Gates Foundation, Wellcome put $550m behind new TB jab

CDC panel backs use of GSK, Pfizer’s RSV shots this year

What would you do if you had 6 months' lead time?

CSL reflects on its future, past as new R&D lab opens

BiomX reports “impressive” data in first bacteriophage trial

Valneva eyes first place in chikungunya vaccine race

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

infectious diseases

Editor's Picks